Fumarate Hydratase-Deficient Renal Cell Carcinoma with Nucleolar Pattern of GATA3 Immunoexpression: Report of 2 Cases

被引：0

作者：

Chaudhry, Sidhartha ^{[1
]}

Kravtsov, Oleksandr ^{[1
]}

机构：

[1] SUNY Upstate Med Univ, Dept Pathol, 750 E Adams St, Syracuse, NY 13210 USA

来源：

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY | 2025年 / 33卷 / 01期

关键词：

fumarate hydratase-deficient renal cell carcinoma; hereditary leiomyomatosis and renal cell cancer syndrome; GATA3; immunohistochemistry; HEREDITARY LEIOMYOMATOSIS; 2SC; FH;

D O I：

10.1177/10668969241253210

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is a rare aggressive type of renal cell carcinoma. The significant morphologic overlap with other types of renal neoplasia and the limited availability of FH and 2-succinylcholine immunostains for diagnostic use outside large referral centers have created numerous diagnostic pitfalls. As FH-deficient RCC can be associated with hereditary leiomyomatosis and renal cell cancer syndrome, the importance of an accurate diagnosis goes beyond the prognosis and treatment of an individual patient. We present 2 patients with FH-deficient RCC showing a peculiar pattern of GATA3 immunoexpression restricted to tumor nucleoli. If confirmed in further larger studies, this could provide an additional diagnostic clue for considering the FH-deficient RCC diagnosis, and given the frequent papillary morphology and possible hilar location can lead to the misdiagnosis as high-grade urothelial carcinoma, and is an important diagnostic pitfall to be aware of.

引用

页码：199 / 203

页数：5

共 50 条

[41] Clinicopathological and molecular features of so-called low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: a study of 5 cases [J].

Xie, Bin ;

Li, Qi ;

Ma, Qiang ;

Huang, Ying ;

Wu, Ze ;

Hu, Zhongliang ;

Feng, Junming ;

Tong, Kuo .

VIRCHOWS ARCHIV, 2025,

[42] Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma [J].

Lindner, Andrea Katharina ;

Tulchiner, Gennadi ;

Seeber, Andreas ;

Siska, Peter J. ;

Thurnher, Martin ;

Pichler, Renate .

FRONTIERS IN ONCOLOGY, 2022, 12

[43] Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors [J].

Hamza, Ameer ;

Sirohi, Deepika ;

Smith, Steven C. ;

Amin, Mahul B. .

ADVANCES IN ANATOMIC PATHOLOGY, 2021, 28 (06) :396-407

[44] Succinate dehydrogenase deficient renal cell carcinoma frequently expresses GATA3 and L1CAM [J].

Sangoi, Ankur R. ;

Williamson, Sean R. ;

Oktay, Murat ;

Gill, Anthony J. ;

Trpkov, Kiril ;

Siadat, Farshid ;

Maclean, Fiona ;

Galea, Laurence A. ;

Baydar, Deniz Ertoy ;

Cakir, Caglar ;

Karabulut, Yasemin Yuyucu ;

Baycelebi, Deniz ;

Coban, Ganime ;

Sarsik, Banu ;

Bayrak, Busra Yaprak ;

Kuthi, Levente ;

Posfai, Boglarka ;

Mobeen, Aysha ;

Mohanty, Sambit K. ;

Zhang, Xulang ;

Alghamdi, Mohammed A. ;

Cheng, Liang ;

Hirsch, Michelle S. ;

Akgul, Mahmut .

VIRCHOWS ARCHIV, 2025, 486 (06) :1247-1256

[45] Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma [J].

Alaghehbandan, Reza ;

Stehlik, Jan ;

Trpkov, Kiril ;

Magi-Galluzzi, Cristina ;

Mundo, Enric Condom ;

Foix, Maria Pane ;

Berney, Daniel ;

Sibony, Mathilde ;

Suster, Saul ;

Agaimy, Abbas ;

Montiel, Delia Perez ;

Pivovarcikova, Kristyna ;

Michalova, Kvetoslava ;

Daum, Ondrej ;

Ondic, Ondrej ;

Rotterova, Pavla ;

Dusek, Martin ;

Hora, Milan ;

Michal, Michal ;

Hes, Ondrej .

ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 29 :17-22

[46] A Case of Metastatic Fumarate Hydratase-Deficient-like Renal Cell Carcinoma Successfully Managed by Ipilimumab plus Nivolumab [J].

Sekito, Takanori ;

Takamoto, Atsushi ;

Kobayashi, Yasuyuki ;

Mitsui, Masao ;

Watari, Shogo ;

Kubota, Risa ;

Sadahira, Takuya ;

Iwata, Takehiro ;

Nishimura, Shingo ;

Edamura, Kohei ;

Sako, Tomoko ;

Araki, Motoo ;

Watanabe, Masami ;

Watanabe, Toyohiko ;

Shibata, Rei ;

Ennishi, Daisuke ;

Nasu, Yasutomo .

ACTA MEDICA OKAYAMA, 2021, 75 (03) :397-402

[47] Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma [J].

Calio, Anna ;

Marletta, Stefano ;

Stefanizzi, Lavinia ;

Marcolini, Lisa ;

Rotellini, Matteo ;

Serio, Gabriella ;

Bariani, Elena ;

Vicentini, Caterina ;

Pedron, Serena ;

Martelli, Filippo M. ;

Antonini, Pietro ;

Brunelli, Matteo ;

Martignoni, Guido .

MODERN PATHOLOGY, 2024, 37 (09)

[48] Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma inHLRCCsyndrome patients with a tailored therapeutic approach [J].

Wyvekens, Nicolas ;

Valtcheva, Nadejda ;

Mischo, Axel ;

Helmchen, Birgit ;

Hermanns, Thomas ;

Choschzick, Matthias ;

Hotker, Andreas M. ;

Rauch, Anita ;

Muhleisen, Beda ;

Akhoundova, Dilara ;

Weber, Achim ;

Moch, Holger ;

Rupp, Niels J. .

GENES CHROMOSOMES & CANCER, 2020, 59 (11) :611-619

[49] SWI/SNF protein expression status in fumarate hydratase-deficient renal cell. carcinoma: immunohisto-chemical analysis of 32 tumors from 28 patients [J].

Agaimy, Abbas ;

Amin, Mahul B. ;

Gill, Anthony ;

Popp, Bernt ;

Reis, Andre ;

Berney, Daniel M. ;

Magi-Galluzzi, Cristina ;

Sibony, Mathilde ;

Smith, Steven C. ;

Suster, Saul ;

Trpkov, Kiril ;

Hes, Ondrej ;

Hartmann, Arndt .

HUMAN PATHOLOGY, 2018, 77 :139-146

[50] Incidence of succinate dehydrogenase and fumarate hydratase deficient renal cell carcinoma based on immunohistochemical, screening with SDHA/SDHB and FH/2SC [J].

Gupta, Sounak ;

Swanson, Amy A. ;

Chen, Ying-Bei ;

Lopez, Tilcia ;

Milosevic, Dragana ;

Kipp, Benjamin R. ;

Leibovich, Bradley C. ;

Thompson, R. Houston ;

Herrera-Hernandez, Loren ;

Cheville, John C. ;

Jimenez, Rafael E. .

HUMAN PATHOLOGY, 2019, 91 :114-122

← 1 2 3 4 5 →